$FOLD News Apple sets intraday record; PetSmart

New Post Public Reply Private Reply Replies (0) Message Board

Aug 30, 2014 at 10:28 AM

$FOLD News

Apple sets intraday record; PetSmart considers sale 1:56 p.m. Aug. 20, 2014 - Ben Eisen
Amicus Therapeutics shares up 25.6% in premarket trade 8:05 a.m. Aug. 20, 2014 - Ciara Linnane
Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial 8:04 a.m. Aug. 20, 2014 - Michael Calia
U.S. stocks rise as risk appetite returns 5:19 p.m. April 29, 2014 - Anora Mahmudova
Twitter rallies ahead of earnings; 3D Systems retreats 3:49 p.m. April 29, 2014 - Sue Chang
U.S. stock futures climb; House prices flat in February 9:19 a.m. April 29, 2014 - Barbara Kollmeyer
Amicus rallies 52% premarket after positive trial results 7:25 a.m. April 29, 2014 - Sara Sjolin
Amicus rallies 52% premarket after positive trial results 7:08 a.m. April 29, 2014 - Sara Sjolin
Amicus stock down after it delays seeking Fabry OK 10:44 a.m. June 17, 2013 - MarketWatch.com
Friday’s biggest gaining and declining stocks 10:45 a.m. Jan. 4, 2013 - Greg Morcroft
Amicus Therapeutics up 11% in premarket 8:52 a.m. Jan. 4, 2013 - Steve Gelsi
Thursday’s movers: Apple ends in red on price cut 6:03 p.m. Dec. 20, 2012 - Sue Chang
Amicus down 45% in premarket 9:44 a.m. Dec. 20, 2012 - Steve Gelsi
Amicus falls 47% in premarket trades 8:52 a.m. Dec. 20, 2012 - Steve Gelsi
Bed Bath shares hurt, Jabil climbs after hours 7:31 p.m. Dec. 19, 2012 - Carla Mozee
Amicus, GlaxoSmithKline say treatment misses goal 6:22 p.m. Dec. 19, 2012 - MarketWatch.com
Amicus Therapeutics shares tumble 49% after hours 5:45 p.m. Dec. 19, 2012 - Carla Mozee
U.S. Hot stocks to watch 7:28 a.m. July 18, 2012 - MarketWatch.com
U.S. may end patents on DNA: report 1:13 p.m. Oct. 30, 2010 - Christopher Hinton
Monday's biggest gaining and declining stocks 4:51 p.m. Oct. 5, 2009 - MarketWatch

InsiderInsights.com Daily Round Up 8/29/14: Prospect Capital, THL Credit, Kindred Biosciences, Select Medical 14 min ago - Seeking Alpha
Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog 10:32 a.m. Aug. 27, 2014 - Zacks.com
Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog 9:49 a.m. Aug. 27, 2014 - Zacks.com
The Biotech Stock With The Best One-Week Performance 2:46 p.m. Aug. 25, 2014 - benzinga.com
Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog 4:55 p.m. Aug. 21, 2014 - Zacks.com
Perilous Reversal Stock: Amicus Therapeutics (FOLD) 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape 9:39 a.m. Aug. 21, 2014 - Zacks.com
Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape 9:03 a.m. Aug. 21, 2014 - Zacks.com
Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript) 3:43 p.m. Aug. 20, 2014 - Seeking Alpha
Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today 10:29 a.m. Aug. 20, 2014 - TheStreet.com
Stocks Hitting 52-Week Highs 9:15 a.m. Aug. 20, 2014 - benzinga.com
Amicus Fabry disease drug candidate successful in Phase 3 trial 7:27 a.m. Aug. 20, 2014 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:10 a.m. Aug. 20, 2014 - benzinga.com
Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win 6:01 a.m. Aug. 20, 2014 - TheStreet.com
Amicus' (FOLD) CEO John Crowley on Q2 2014 Results - Earnings Call Transcript 9:37 p.m. Aug. 7, 2014 - Seeking Alpha
10-Q: AMICUS THERAPEUTICS INC 5:07 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why Amicus Therapeutics (FOLD) Might Surprise This Earnings Season - Tale of the Tape 8:44 a.m. Aug. 6, 2014 - Zacks.com
Amicus (FOLD) Shares March Higher, Can It Continue? - Tale of the Tape 11:11 a.m. July 29, 2014 - Zacks.com
Applied Genetic Technologies Corporation (AGTC) Looks Strong as Stock Surges 15.3% - Tale of the Tape 8:44 a.m. July 28, 2014 - Zacks.com
Agenus Inc. (AGEN) Looks Strong as Stock Surges 11.15% - Tale of the Tape 8:44 a.m. July 25, 2014 - Zacks.com

Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo 8:40 a.m. Aug. 25, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012 6:00 a.m. Aug. 20, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. Aug. 7, 2014 - GlobeNewswire
Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014 4:01 p.m. July 31, 2014 - GlobeNewswire
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 8:50 a.m. July 30, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc. 2:55 p.m. July 7, 2014 - PR Newswire - PRF
Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array 6:30 a.m. July 3, 2014 - PR Newswire - PRF
Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012 7:00 a.m. June 30, 2014 - GlobeNewswire
Technical Coverage on Top Gainers -- Research on Fresh Market, First Bancorp, Amicus Therapeutics, and Magellan Petroleum 8:20 a.m. June 4, 2014 - PR Newswire - PRF
Amicus Therapeutics to Present at UBS Global Healthcare Conference 4:10 p.m. May 14, 2014 - GlobeNewswire
Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. May 5, 2014 - GlobeNewswire
Dr. Farzad Mostashari to keynote SAS Health Analytics Executive Conference 10:30 a.m. May 5, 2014 - BusinessWire - BZX
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Amicus Therapeutics to Announce First Quarter 2014 10:01 a.m. May 1, 2014 - GlobeNewswire
Morning Review on Top Gainers -- Research on Banco Santander Brasil, Novavax, Cadence Design Systems, and Amicus Therapeutics 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive 12- and 24-Month Data From Phase 3 Fabry Monotherapy Study 011 6:01 a.m. April 29, 2014 - GlobeNewswire
Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference 4:39 p.m. March 27, 2014 - GlobeNewswire
Amicus Therapeutics Announces Full-Year 2013 Financial Results and Corporate Updates 5:01 p.m. March 3, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SecureSpace Expands into Dallas-Fort Worth Market

A New Player in Dallas-Fort Worth SecureSpace Self Storage has stormed into the Dallas-Fort Worth area, ushering in a sizeable expansion with four brand-new locations. This move is big news for the self-storage operator, marking its very first foray into the Texan market and boosting its nationwide presence past that century mark – 101 stores and counting. Call it a...

Blackbird Health Expands Northern VA Mental Health Care

Another Piece to the Puzzle in Pediatric Care Consider this a lifeline tossed to the scrambling families of Northern Virginia. Blackbird Health's newest clinic in Sterling is throwing open its doors to more kids and parents. Right now, the stakes couldn't be higher for families tangled in mental health mysteries, looking for every shred of support they can find. Answering...

Zeelo Strengthens West Coast Expansion with Zoss Hire

Zeelo's got itself a new captain steering its West Coast ship, and it’s none other than transportation whiz Gillian Zoss. Now, when a company like Zeelo pulls a move like this, it's worth taking a moment to chew over the implications. Zeelo's been known for shaking up how folks think about moving people—employees, kids to schools, you name it—their model's rattled a...

Coretek Joins CRN's Elite AI Innovators of 2026

Coretek's Leap to AI Innovator Status Here we are, folks. Another announcement hits the wires that showcases a company's ascent amid the swelling AI tide. Coretek, hailing from Farmington Hills, managed to snag a spot on CRN's inaugural 2026 AI Innovators list. No small potatoes, if you ask me, considering the competition on this playing field. Why the fuss? It's about...

Gildan Activewear Faces Investor Class Action Shakeup

Welcome to the Wild World of Securities You know what's wilder than a bull market run? This latest spin in the securities fraud realm starring Gildan Activewear Inc. (NYSE:GIL). The backdrop? Hagens Berman, the heavy hitters in legal circles specializing in securities fraud and shareholder rights, have rolled up their sleeves and filed a class action lawsuit against...

Brightstar's iCAP Ready Badge: A Gamble on Responsibility

Another Feather in Brightstar's Cap You might not toss 'responsible gaming standards' around in casual talk, but in the gaming biz, it's a badge of honor. Brightstar Lottery PLC (NYSE: BRSL) ain't just spinning wheels here—they've got themselves re-accredited with iCAP Ready from the National Council on Problem Gambling (NCPG). It's the stamp of approval that shows...

AllianceBernstein Unveils Income-Focused ETF Amid Volatile Times

Diving into AllianceBernstein's New Income ETF Well, today we’ve got something stirring in the financial waters over at AllianceBernstein. They’ve launched a new exchange-traded fund (ETF), aptly named the AB Equity Premium Income ETF [INK]. Now, if you’re wondering what’s cooking with this newcomer on the NASDAQ, let’s crack it open and see what’s under the...

Curaleaf Eyes Aurora Amid Alternative from Organigram

Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...

Ampace Shifts Focus to Reliability in Two-Wheeler Batteries

Here's a Shift: Reliability Over Specs Alright, folks, buckle up because Ampace is shaking things up at EICMA Milan this year. While some are still yammering on about juicing up specs, Ampace is talking reliability. It's a bold move in the fast-evolving two-wheeler battery market, where everyone's been obsessed with horsepower and max speeds. The landscape's shifting...

Virginia Home Projects: Navigating 2026 Material Costs

Penny-Pinching with Pricey Planks: Lumber's Wild Ride Every single time you pick up a hammer, it's like gambling on the money pit that is lumber pricing. These costs are so all over the board in 2026, they make whipping your checkbook out feel like a game of roulette. Folks over in Culpeper and the greater Virginia space are no strangers to this chaotic dance. Travis...